BlackRock, Inc. Reduces Stake in Dolby Laboratories (DLB) to 10.0%

2026-06-04SEC Filing SCHEDULE 13G/A (0002012383-26-001861)

On June 4, 2026, BlackRock, Inc. filed an amended Schedule 13G (Amendment No. 2) regarding its holdings in Dolby Laboratories, Inc. (DLB). The filing indicates that as of May 31, 2026, BlackRock beneficially owns 6,041,219 shares of Class A Common Stock, representing 10.0% of the class. This reflects a decrease from its previously reported position of 6,538,336 shares. Of the total shares held, BlackRock reported sole voting power over 5,849,800 shares and sole dispositive power over the full 6,041,219 shares. The filing specifies that various persons have the right to receive dividends or sale proceeds, but no single person's interest exceeds 5% of the total outstanding common shares. As a parent holding company, BlackRock's filing includes shares held across various business units and subsidiaries. The securities were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.